| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY USING A MASTER PROTOCOL TO EVALUATE NOVEL IMMUNOTHERAPY COMBINATIONS AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH RECURRENT/METASTATIC PD-L1 POSITIVE SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK |
II |
in corso |
CARCINOMA A CELLULE SQUAMOSE DELLA TESTA E DEL COLLO |
- SC Oncologia Clinica Sperimentale Testa – Collo |
|
A PHASE 2/3, MULTICENTER, RANDOMIZED STUDY OF RALUDOTATUG DERUXTECAN (R-DXD), A CDH6-DIRECTED ANTIBODY-DRUG CONJUGATE,IN SUBJECTS WITH PLATINUM-RESISTANT, HIGH-GRADE OVARIAN, PRIMARY PERITONEAL, OR FALLOPIAN TUBE CANCER (DOSE OPTIMIZATION AND PHASE 3 STUDY OF R-DXD VERSUS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN PLATINUM RESISTANT OVARIAN CANCER) |
II/III |
in corso |
Tumore ovarico, del peritoneo o delle tube di Falloppio |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
TERAPIE DI SUPPORTO AL TRATTAMENTO FARMACOLOGICO STANDARD ANTITUMORALE IN PAZIENTI CON TUMORE TESTA-COLLO IN STADIO AVANZATO”- IMPROVE H&N-RICERCA CORRENTE L1/10 |
NA |
in corso |
Tumori Testa Collo |
SC Oncologia Clinica Sperimentale Testa – Collo - |
|
SUNRAY-01, uno studio registrativo globale in partecipanti con tumore del polmone non a piccole cellule localmente avanzato o metastatico, KRAS G12C-mutato, che compara in prima linea di trattamento LY3537982 + Pembrolizumab vs Placebo + Pembrolizumab in chi ha una espressione del PD-L1 ≥50% oppure LY3537982 + Pembrolizumab, Pemetrexed, Platino vs Placebo + Pembrolizumab, Pemetrexed, Platino indipendentemente dall’ espressione del PD-L1 |
III |
in corso |
tumore del polmone non a piccole cellule |
- SC Oncologia Clinica Sperimentale Toraco - Polmonare |
|
A PHASE 3, RANDOMIZED, OPEN-LABEL, STUDY TO COMPARE THE EFFICACY AND SAFETY OF ADJUVANT MK-2870 IN COMBINATION WITH PEMBROLIZUMAB (MK-3475) VERSUS TREATMENT OF PHYSICIAN’S CHOICE (TPC) IN PARTICIPANTS WITH TRIPLE-NEGATIVE BREAST CANCER (TNBC) WHO RECEIVED NEOADJUVANT THERAPY AND DID NOT ACHIEVE A PATHOLOGICAL COMPLETE RESPONSE (PCR) AT SURGERY |
II |
in corso |
Carcinoma mammario |
- SC Oncologia Clinica Sperimentale di Senologia |
